Financial Risk Influencing Factors and Control Mechanisms in the Pharmaceutical Sector
DOI:
https://doi.org/10.54097/dkqmth42Keywords:
Pharmaceutical Industry; Financial Risk; Risk Prevention and Control.Abstract
This paper focuses on the financial risks of China's pharmaceutical industry. Driven by policy support and rigid demand, the industry maintains an overall expansion trend but has entered an in-depth adjustment period with prominent structural risks. The main financial risks stem from three core factors: macroeconomic cyclical fluctuations, policy adjustments such as medical insurance cost control and centralized procurement, and capital market valuation regression and financing differentiation. Small and medium-sized enterprises are under greater survival pressure due to structural contradictions. To address these risks, a multi-dimensional collaborative system featuring enterprise-led prevention and control, policy-guided guarantee, and market environment optimization is proposed. Enterprises, government departments, and the capital market need to work together to promote the industry's transformation from scale expansion to quality and efficiency improvement, ensuring its sustainable and healthy development.
Downloads
References
[1] Shi Ju, Wang Xiaoqian, Wang Xi. Micro Medical Expense Forecasting Models: From Linear Regression to Machine Learning. China Economic Quarterly, 2023, 23(6): 2247-2263.
[2] Zeng Rong, Zhou Yunlan, Yang Jingjing. A Comparative Study of Financial Early Warning Models Based on Pharmaceutical Industry Data. Communication of Finance and Accounting, 2013, (20): 110-112.
[3] Koyuncugil A S, Ozgulbas N. Early Warning System for Financially Distressed Hospitals via Data Mining Application. Journal of Medical Systems, 2012, 36(4): 2271-2287. DOI: https://doi.org/10.1007/s10916-011-9694-1
[4] Gholampoor H, Asadi M. Risk Analysis of Bankruptcy in the U.S. Healthcare Industries Based on Financial Ratios: A Machine Learning Analysis. Journal of Theoretical and Applied Electronic Commerce Research, 2024, 19(2): 1303-1320. DOI: https://doi.org/10.3390/jtaer19020066
[5] Beauvais B, Ramamonjiarivelo Z, Betancourt J, Cruz J, Fulton L. The Predictive Factors of Hospital Bankruptcy—An Exploratory Study. Healthcare, 2023, 11(2): 165. DOI: https://doi.org/10.3390/healthcare11020165
[6] Elloumi F, Gueyié J F. Financial Distress and Corporate Governance: An Empirical Analysis. Corporate Governance, 2001, 1(1): 15-23. DOI: https://doi.org/10.1108/14720700110389548
[7] Lv Xuejing, Chen Zhibin, Li Dongyang. Government Regulation and Corporate Financial Risk: Empirical Evidence from China's A-Share Listed Companies. Accounting and Economic Research, 2020, 34(5): 56-67.
[8] Wang Shiyu, Chen Zhihong. The Evolution of Corporate Financial Risk and Its Industry Effect: A Dual Context Analysis Based on Regulatory Environment and Competitive Environment. Accounting Research, 2018, (11): 56-62.
[9] Duan Haiyan. Research on the Impact of Financial Capital from Different Sources on Enterprise R&D Investment: A Case Study of SMEs Listed on the Small and Medium Enterprise Board. Science & Technology Progress and Policy, 2016, 33(14): 88-92.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Highlights in Business, Economics and Management
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
